Amphastar Pharmaceuticals (AMPH) EPS (Diluted) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EPS (Diluted) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 496.37 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.58% |
| Mar 31, 2026 | 11.57% |
| Dec 31, 2025 | 48.24% |
| Sep 30, 2025 | 30.50% |
| Jun 30, 2025 | 87.37% |
| Mar 31, 2025 | 47.31% |
| Dec 31, 2024 | 7.38% |
| Sep 30, 2024 | 108.78% |
| Jun 30, 2024 | -4.96% |
| Mar 31, 2024 | 84.39% |
| Dec 31, 2023 | 77.65% |
| Sep 30, 2023 | 94.01% |
| Jun 30, 2023 | 58.87% |
| Mar 31, 2023 | 39.91% |
| Dec 31, 2022 | 22.87% |
| Sep 30, 2022 | 171.66% |
| Jun 30, 2022 | 51.67% |
| Mar 31, 2022 | 91.62% |
| Dec 31, 2021 | 80.45% |
| Sep 30, 2021 | 50.15% |